Author： Scheff Thomas J.
Publisher： Springer Publishing Company
ISSN： 1559-4343
Source： Ethical Human Psychology and Psychiatry, Vol.11, Iss.1, 2009-04, pp. : 37-49
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 3, 2002-09 ,pp. :
Access to resources
Recommend
Fluvoxamine in the treatment of severe depression
By Zohar Joseph
Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. :
Treatment of cytokine-induced depression
By Capuron L. Hauser P. Hinze-Selch D. Miller A.H. Neveu P.J.
Brain, Behavior, and Immunity, Vol. 16, Iss. 5, 2002-10 ,pp. :
Challenges in depression detection and treatment
Nordic Journal of Psychiatry, Vol. 64, Iss. 4, 2010-08 ,pp. :
Venlafaxin for the treatment of psychotic depression
European Psychiatry, Vol. 13, Iss. 5, 1998-08 ,pp. :